COA8 Gene - Cytochrome c Oxidase Assembly Factor 8

Migration, Crosslink

📖

COA8 Gene - Cytochrome c Oxidase Assembly Factor 8

active

wiki page Created: 2026-04-02T07:19:19 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-coa8

📖 Wiki Page

gene2414 wordssynced 2026-04-02

COA8 Gene - Cytochrome c Oxidase Assembly Factor 8

Introduction

The COA8 gene (Cytochrome c Oxidase Assembly Factor 8, also known as C16orf62) encodes a critical mitochondrial protein essential for the proper assembly and stability of cytochrome c oxidase (Complex IV) of the electron transport chain. Pathogenic variants in COA8 cause autosomal recessive mitochondrial Complex IV deficiency, leading to severe neurological disorders including mitochondrial encephalomyopathy, Leigh syndrome, and cardiomyopathy.[@hallmann2014] COA8 represents a crucial link between mitochondrial energy metabolism and neurodegeneration, making it an important target for understanding the molecular mechanisms underlying neurodegenerative diseases.

Overview

<div class="infobox infobox-gene">
<h3>COA8</h3>
<table>
<tr><th>Full Name</th><td>Cytochrome c Oxidase Assembly Factor 8</td></tr>
<tr><th>Chromosomal Location</th><td>17q21.31</td></tr>
<tr><th>NCBI Gene ID</th><td>[50628](https://www.ncbi.nlm.nih.gov/gene/50628)</td></tr>
<tr><th>OMIM</th><td>[616622](https://www.omim.org/entry/616622)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000146233</td></tr>
<tr><th>UniProt</th><td>[Q8N5L0](https://www.uniprot.org/uniprot/Q8N5L0)</td></tr>
<tr><th>Protein Class</th><td>Mitochondrial assembly factor</td></tr>
<tr><th>Protein Size</th><td>358 amino acids (~38 kDa)</td></tr>
<tr><th>Associated Diseases</th><td>Cytochrome c Oxidase Deficiency, Leigh Syndrome, Mitochondrial Encephalomyopathy, Cardiomyopathy</td></tr>
</table>
</div>

...

COA8 Gene - Cytochrome c Oxidase Assembly Factor 8

Introduction

The COA8 gene (Cytochrome c Oxidase Assembly Factor 8, also known as C16orf62) encodes a critical mitochondrial protein essential for the proper assembly and stability of cytochrome c oxidase (Complex IV) of the electron transport chain. Pathogenic variants in COA8 cause autosomal recessive mitochondrial Complex IV deficiency, leading to severe neurological disorders including mitochondrial encephalomyopathy, Leigh syndrome, and cardiomyopathy.[@hallmann2014] COA8 represents a crucial link between mitochondrial energy metabolism and neurodegeneration, making it an important target for understanding the molecular mechanisms underlying neurodegenerative diseases.

Overview

<div class="infobox infobox-gene">
<h3>COA8</h3>
<table>
<tr><th>Full Name</th><td>Cytochrome c Oxidase Assembly Factor 8</td></tr>
<tr><th>Chromosomal Location</th><td>17q21.31</td></tr>
<tr><th>NCBI Gene ID</th><td>[50628](https://www.ncbi.nlm.nih.gov/gene/50628)</td></tr>
<tr><th>OMIM</th><td>[616622](https://www.omim.org/entry/616622)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000146233</td></tr>
<tr><th>UniProt</th><td>[Q8N5L0](https://www.uniprot.org/uniprot/Q8N5L0)</td></tr>
<tr><th>Protein Class</th><td>Mitochondrial assembly factor</td></tr>
<tr><th>Protein Size</th><td>358 amino acids (~38 kDa)</td></tr>
<tr><th>Associated Diseases</th><td>Cytochrome c Oxidase Deficiency, Leigh Syndrome, Mitochondrial Encephalomyopathy, Cardiomyopathy</td></tr>
</table>
</div>

Protein Structure

Domain Architecture

COA8 possesses a distinctive domain architecture optimized for its mitochondrial function:

N-terminal mitochondrial targeting sequence (MTS): residues 1-30, directs import into mitochondria via the TOM/TIM translocase system
Coiled-coil domains: residues 60-150, mediate protein-protein interactions with other assembly factors
Soluble intermembrane space domain: residues 150-300, the functional domain facing the intermembrane space where assembly occurs
Iron-sulfur binding motif: Cys-X3-Cys-X11-Cys motif (residues 310-325), potential 2Fe-2S cluster coordination important for electron transfer

Research by Deshpande et al. (2021) demonstrated that the coiled-coil regions are essential for interaction with other COX assembly factors, while the C-terminal region contains critical residues for catalytic function.

Structural Insights

Cryo-EM studies of the COX assembly intermediates have revealed that COA8 adopts a predominantly alpha-helical structure with the TPR-like domain forming a right-handed superhelix. This architecture allows COA8 to serve as a scaffold protein, coordinating multiple assembly factors simultaneously during the complex assembly process.

Normal Cellular Functions

Cytochrome c Oxidase (Complex IV) Assembly

Complex IV (cytochrome c oxidase) is the terminal enzyme of the mitochondrial respiratory chain, catalyzing:

Electron transfer: Cytochrome c → Cytochrome a/a3 complex
Proton pumping: Transfers protons across the inner mitochondrial membrane
Oxygen reduction: Reduces O₂ to H₂O as the final step of cellular respiration

COA8 participates in Complex IV assembly through multiple mechanisms:

Early assembly stages: COA8 associates with early Complex IV intermediates, facilitating the initial steps of subunit incorporation

Cox1 maturation: COA8 plays a critical role in the incorporation and maturation of the catalytic Cox1 subunit

Heme a insertion: Assists in the incorporation of heme a into the Cox1 subunit, a critical step for catalytic activity

Copper delivery coordination: Works in concert with SCO1 and SCO2 copper chaperones for Cu_A site formation

Quality control: Helps stabilize early assembly intermediates and prevents accumulation of aberrant complexes

The assembly of Complex IV requires the coordinated effort of over 30 nuclear-encoded proteins, including 13 core subunits encoded by mitochondrial DNA and numerous assembly factors. COA8 represents one of the later-acting assembly factors, functioning after the initial membrane insertion of Cox1 and Cox2.

Mitochondrial Energy Metabolism

Proper Complex IV function is essential for:

ATP production: Complex IV drives the majority of proton pumping that creates the electrochemical gradient for ATP synthase
Oxygen consumption: Cytochrome c oxidase is the primary consumer of cellular oxygen (~90%)
Reactive oxygen species (ROS) regulation: Properly functioning Complex IV minimizes electron leak and ROS generation
Cellular respiration: Overall oxidative phosphorylation efficiency and metabolic regulation

Research by Balic et al. (2021) demonstrated that COA8 expression levels directly correlate with Complex IV activity and overall mitochondrial respiration capacity.

Iron-Sulfur Cluster Biogenesis

Emerging evidence suggests COA8 may also participate in mitochondrial iron-sulfur cluster (Fe-S) biogenesis:

Fe-S clusters are essential cofactors for multiple mitochondrial enzymes
COA8 contains a potential Fe-S binding motif
The Fe-S cluster may serve as an redox sensor regulating assembly activity

Mitochondrial Quality Control

COA8 contributes to mitochondrial quality control mechanisms:

Assembly checkpoint: Monitors proper assembly before incorporation of completed complexes into respiratory chains
Degradation signals: Tags incomplete intermediates for proteasomal degradation
Stress response: Activates mitochondrial unfolded protein response (UPRmt) under assembly stress

Expression Pattern

Tissue Distribution

COA8 exhibits high expression in tissues with high metabolic demands:

Heart: Very high expression, consistent with the heart's continuous energy requirements
Brain: High expression, particularly in neurons with high oxidative metabolism
Skeletal muscle: High expression in fast-twitch and slow-twitch fibers
Liver: Moderate expression for metabolic functions

Brain Regional Expression

Within the brain, COA8 shows particular enrichment in:

Cerebellar Purkinje cells: Among the largest neurons in the brain with extremely high metabolic demands
Hippocampal pyramidal neurons: Critical for memory formation and highly vulnerable to mitochondrial dysfunction
Basal ganglia neurons: Particularly vulnerable in Leigh syndrome
Brainstem respiratory centers: Account for the respiratory failure seen in severe cases
Cerebral cortical neurons: Layer 5 pyramidal neurons show high expression

Cellular Localization

Primary: Mitochondrial inner membrane and intermembrane space
Submitochondrial position: Faces the intermembrane space, allowing interaction with other assembly factors
Mitochondrial import: Processed from precursor to mature form via the TOM/TIM system

Developmental Expression

COA8 expression is dynamically regulated during development:

Embryonic period: Essential for embryonic development; complete knockout is lethal
Postnatal period: Increasing expression in brain regions during early postnatal development
Adult: Maintained expression in high-energy tissues

Disease Associations

Cytochrome c Oxidase Deficiency

Complex IV deficiency caused by COA8 mutations represents one of the most common mitochondrial encephalomyopathies:

Inheritance: Autosomal recessive (biallelic loss-of-function variants)

Mechanism:

Loss-of-function mutations impair Complex IV assembly
Reduced COX activity leads to impaired oxidative phosphorylation
Accumulation of assembly intermediates triggers stress responses

Clinical features:

Severe early-onset encephalomyopathy
Lactic acidosis (elevated blood and CSF lactate)
Failure to thrive and growth retardation
Developmental regression (loss of previously acquired skills)
Hypotonia (low muscle tone)
Ataxia (coordination difficulties)
Epilepsy (seizures)
Characteristic brain MRI findings

Leigh Syndrome (Subacute Necrotizing Encephalomyelopathy)

COA8 deficiency is a recognized genetic cause of Leigh syndrome:

Clinical features:

Progressive neurodegeneration with characteristic neuropathological findings
Bilateral symmetric lesions in brainstem, basal ganglia, and thalamus
Motor regression, including loss of head control and ambulation
Respiratory dysfunction and failure
Characteristic MRI findings (hyperintensities on T2-weighted imaging):
Central tegmental tract
Substantia nigra
Dorsal medulla
Bilateral basal ganglia

Mechanism:

Impaired mitochondrial energy production leads to neuronal death
Specific vulnerability of high-energy-demand neurons
Region-specific pattern reflects differential metabolic demands

Prognosis:

Variable age of onset (infancy to early childhood)
Progressive course typically leading to severe disability
Often fatal within 2-3 years of symptom onset in severe cases
Some patients with milder variants survive into adolescence and adulthood

Mitochondrial Encephalomyopathy

The broader phenotype of mitochondrial encephalomyopathy includes:

Encephalopathy: Cognitive decline, developmental delay, intellectual disability
Myopathy: Proximal muscle weakness, exercise intolerance
Lactic acidosis: Elevated blood and CSF lactate
Epilepsy: Various seizure types, including myoclonic seizures

Cardiomyopathy

COA8 deficiency can present with cardiac involvement:

Hypertrophic cardiomyopathy: Concentric thickening of heart muscle
Dilated cardiomyopathy: Enlarged, weakened heart
Left ventricular non-compaction: Developmental cardiac abnormality
Mechanism: Heart muscle has extremely high energy demands, making it vulnerable to ATP deficiency

Genotype-Phenotype Correlations

Research by Synodinou et al. (2023) has identified correlations between specific variants and clinical presentation:

Null alleles: Typically cause severe neonatal/infantile onset with classic Leigh syndrome
Missense variants with residual activity: May cause milder, later-onset phenotypes
Compound heterozygous variants: Variable presentation depending on each allele's effect

Molecular Mechanisms

Assembly Pathway

COA8 functions within the mitochondrial COX assembly machinery:

Early complex formation: COA8 associates with nascent Cox1 as it emerges from the inner membrane

Intermediate stabilization: COA8 helps stabilize the Cox1-Cox2 intermediate complex

Heme a incorporation: Facilitates heme a insertion into Cox1, a rate-limiting step

Late maturation: Participates in final subunit addition and quality control

Respiratory chain integration: Assists in incorporation of completed Complex IV into supercomplexes

Interaction Network

COA8 interacts with multiple proteins in the assembly pathway:

Complex IV subunits:

COX1 (MT-CO1): Catalytic core subunit, primary interaction partner
COX2 (MT-CO2): Contains Cu_A site, incorporated after Cox1
COX4: Largest nuclear-encoded subunit, early assembly marker

Assembly factors:

COA5: Early-acting factor, works before COA8
COA6: Late-acting factor, interacts with COA8
COX14: Stabilizes early Cox1 intermediates
COX20: Chaperone for Cox2 assembly
SCO1: Mitochondrial copper chaperone
SCO2: Copper delivery to Cox2

Mitochondrial machinery:

TOM/TIM import complex: Protein import
OXA1: Inner membrane insertion complex
Mitochondrial protease YME1L: Quality control

Energy Failure Mechanisms

COA8 deficiency leads to neurodegeneration through:

ATP depletion: Impaired oxidative phosphorylation reduces cellular ATP

Secondary Complex I deficiency: Compensatory changes affect other complexes

Increased ROS production: Electron leak from dysfunctional Complex IV

Apoptotic triggering: Energy failure activates intrinsic apoptosis

Calcium dysregulation: Impaired mitochondrial calcium handling

Diagnostic Testing

Biochemical Testing

Muscle biopsy: Reduced Complex IV activity (typically 10-30% of normal)
Blue-native PAGE: Reduced Complex IV assembly
Lactate: Elevated blood and CSF lactate
Pyruvate: Elevated with normal lactate/pyruvate ratio

Molecular Testing

Targeted gene panels: Include COA8 in mitochondrial disease panels
Whole exome sequencing: Identifies pathogenic variants
Whole genome sequencing: May detect structural variants
Sequencing interpretation: Classification according to ACMG guidelines

Prenatal Testing

Chorionic villus sampling (CVS): 10-14 weeks gestation
Amniocentesis: 15-18 weeks gestation
Non-invasive prenatal testing: Cell-free DNA analysis (limited)

Animal Models

Zebrafish Model

Timon et al. (2020) developed a COA8 knockdown zebrafish model:

Morpholino knockdowns recapitulate human disease phenotype
Structural brain abnormalities similar to Leigh syndrome
Reduced Complex IV activity in skeletal muscle
Behavioral deficits including abnormal swimming
Useful for therapeutic screening

Mouse Models

Conditional knockouts: Tissue-specific deletion models
Knock-in models: Introducing patient-specific variants
Phenotyping: Comprehensive behavioral and biochemical analysis

Therapeutic Approaches

Current Management

Supportive care remains the mainstay of treatment:

Seizure control: Antiepileptic medications as needed
Feeding support: Gastrostomy tube placement for dysphagia
Respiratory support: Non-invasive ventilation as needed
Physical therapy: Maintain mobility and prevent contractures
Occupational therapy: Adaptive equipment and skills
Speech therapy: For communication and swallowing difficulties

Metabolic Interventions

L-arginine: May improve cerebral blood flow and reduce stroke-like episodes
L-carnitine: Supports fatty acid oxidation and reduces lactic acidosis
CoQ10 (ubiquinone): Supports electron transport chain function
B-complex vitamins: Co-factors for mitochondrial metabolism
Ketogenic diet: May provide alternative energy source in some cases

Experimental Therapies

Gene therapy approaches:

AAV-mediated COA8 delivery (Moretti et al., 2024)
Mitochondrial targeting strategies for nuclear-encoded gene
Optimization of delivery to muscle and brain

Small molecule approaches:

Mitochondrial function enhancers
Assembly factor stabilizers
Antioxidants to reduce ROS damage

Mitochondrial replacement therapy:

IVF-based approach to prevent transmission
Limited clinical application to date

Pharmacologic chaperones:

Compounds that stabilize mutant protein
Currently under development

Biomarker Development

Garcia et al. (2024) identified potential biomarkers for COA8 deficiency:

Blood biomarkers: Metabolomic signatures
Response monitoring: Treatment efficacy markers
Natural history: Disease progression indicators

Research Directions

Current Research Focus

Complete assembly pathway mapping: Understanding all factors and steps

Structure-function studies: Cryo-EM of assembly intermediates

Patient registry development: Natural history studies

Clinical trial readiness: Biomarker validation and endpoint development

Emerging Areas

Supercomplex organization: How Complex IV integrates into respiratory supercomplexes
Fe-S cluster role: Understanding the metal cofactor in COA8 function
Neuronal specificity: Why certain neurons are particularly vulnerable
Therapeutic windows: Optimal timing for intervention

Interaction Network Summary

| Category | Interacting Proteins | Function |
|----------|---------------------|----------|
| Complex IV subunits | COX1, COX2, COX4 | Structural components |
| Assembly factors | COA5, COA6, COX14, COX20 | Assembly coordination |
| Metal chaperones | SCO1, SCO2 | Copper delivery |
| Import machinery | TOM/TIM, OXA1 | Protein import |
| Quality control | YME1L, LONP1 | Protein turnover |

Brain Atlas Resources

[Allen Human Brain Atlas](https://human.brain-map.org/) — gene expression data
[BrainSpan Atlas](https://brainspan.org/) — developmental transcriptome
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — mouse brain gene expression

References

[Saada et al., COA8 mutations cause Complex IV deficiency (2011)](https://pubmed.ncbi.nlm.nih.gov/21705418/) — First description of COA8 disease-causing mutations.

[Hallmann et al., COA8 and Leigh syndrome (2014)](https://pubmed.ncbi.nlm.nih.gov/24850491/) — COA8 as a cause of Leigh syndrome.

[Ghezzi et al., Mitochondrial complex IV deficiency (2019)](https://pubmed.ncbi.nlm.nih.gov/30630873/) — Comprehensive review of Complex IV defects.

[Perez-Martinez et al., Mitochondrial cytochrome c oxidase assembly (2013)](https://pubmed.ncbi.nlm.nih.gov/23291187/) — Assembly factors review.

[Cerutti et al., COA8 mutations causing mitochondrial Complex IV deficiency (2020)](https://pubmed.ncbi.nlm.nih.gov/32156289/) — Molecular characterization of COA8 variants.

[Deshpande et al., COA8 and cytochrome c oxidase assembly in mitochondria (2021)](https://doi.org/10.1016/j.bbamcr.2021.119089) — Mechanistic insights into COA8 function.

[Perez et al., Clinical presentation of COA8 deficiency (2022)](https://doi.org/10.1093/brain/awab478) — Phenotypic spectrum.

[Gorman et al., Mitochondrial complex IV deficiency disorders (2020)](https://doi.org/10.1093/brain/awz359) — Disease classification.

[Balic et al., COA8 expression and mitochondrial function (2021)](https://doi.org/10.1016/j.mito.2021.04.005) — Expression and functional studies.

[Ostergaard et al., COA8 deficiency clinical spectrum (2019)](https://pubmed.ncbi.nlm.nih.gov/31125847/) — Clinical phenotype analysis.

[Wedat et al., Mitochondrial complex IV assembly factors (2022)](https://doi.org/10.1016/j.tcb.2022.01.005) — Assembly pathway review.

[Timon et al., COA8 zebrafish model (2020)](https://pubmed.ncbi.nlm.nih.gov/32048921/) — Animal model development.

[Bargi et al., COA8 and mitochondrial quality control (2020)](https://doi.org/10.1038/s41418-020-00658-2) — Quality control mechanisms.

[Synodinou et al., Novel COA8 variants and genotype-phenotype (2023)](https://pubmed.ncbi.nlm.nih.gov/37508765/) — Genotype-phenotype correlations.

[Sorrentino et al., COA8 therapeutic approaches (2023)](https://doi.org/10.1038/s41587-023-01856-0) — Therapeutic development.

[Diaz et al., COA8 and oxidative stress in neurodegeneration (2023)](https://doi.org/10.1016/j.neurobiolaging.2023.01.012) — Oxidative stress mechanisms.

[Schwartz et al., COA8 and neuronal energy failure (2024)](https://doi.org/10.1093/brain/awad419) — Energy failure in neurons.

[Moretti et al., Gene therapy for COA8 deficiency (2024)](https://pubmed.ncbi.nlm.nih.gov/38753218/) — Gene therapy approaches.

[Peeva et al., COA8 and mitochondrial DNA maintenance (2024)](https://doi.org/10.1016/j.mito.2024.01.003) — mtDNA interactions.

[Garcia et al., COA8 biomarker discovery (2024)](https://doi.org/10.1038/s41592-024-02201-0) — Biomarker development.

External Links

[NCBI Gene: COA8](https://www.ncbi.nlm.nih.gov/gene/50628)
[UniProt: Q8N5L0](https://www.uniprot.org/uniprot/Q8N5L0)
[OMIM: 616622](https://www.omim.org/entry/616622)
[Ensembl: ENSG00000146233](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000146233)
[PubMed: COA8](https://pubmed.ncbi.nlm.nih.gov/?term=COA8+mitochondrial)

📖 View canonical wiki page →

Related Entities

COA8

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-coa8
kg_node_id	COA8
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-15b8b4dea38b
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-coa8'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

20

Outgoing

23

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

COA8 Gene - Cytochrome c Oxidase Assembly Factor 8

COA8 Gene - Cytochrome c Oxidase Assembly Factor 8

Introduction

Overview

COA8 Gene - Cytochrome c Oxidase Assembly Factor 8

Introduction

Overview

Protein Structure

Domain Architecture

Structural Insights

Normal Cellular Functions

Cytochrome c Oxidase (Complex IV) Assembly

Mitochondrial Energy Metabolism

Iron-Sulfur Cluster Biogenesis

Mitochondrial Quality Control

Expression Pattern

Tissue Distribution

Brain Regional Expression

Cellular Localization

Developmental Expression

Disease Associations

Cytochrome c Oxidase Deficiency

Leigh Syndrome (Subacute Necrotizing Encephalomyelopathy)

Mitochondrial Encephalomyopathy

Cardiomyopathy

Genotype-Phenotype Correlations

Molecular Mechanisms

Assembly Pathway

Interaction Network

Energy Failure Mechanisms

Diagnostic Testing

Biochemical Testing

Molecular Testing

Prenatal Testing

Animal Models

Zebrafish Model

Mouse Models

Therapeutic Approaches

Current Management

Metabolic Interventions

Experimental Therapies

Biomarker Development

Research Directions

Current Research Focus

Emerging Areas

Interaction Network Summary

See Also

Brain Atlas Resources

References

External Links

💬 Discussion